Recipient Versus Donor CYP3A4/5 Genotypes in Adult Liver Transplant Recipients to Achieve Therapeutic Tacrolimus Concentrations Early Post‐Transplant

Documenti analoghi

• Association of Metabolic Genotype Composite CYP3A5*3 and CYP3A4*1B to Tacrolimus Pharmacokinetics in Stable Black and White Kidney Transplant Recipients
  di: Daniel Brazeau, et al.
  Pubblicazione: (2025)
• Identification of Urinary Exosomal microRNAs Associated With Subclinical Acute T‐Cell‐Mediated Rejection in Kidney Transplant Recipients
  di: Soichiro Tajima, et al.
  Pubblicazione: (2026)
• Comparing Whole‐Blood and Plasma Tacrolimus Intra‐Patient Variability for Predicting Allograft Rejection in Kidney Transplantation
  di: Zeyu Xia, et al.
  Pubblicazione: (2026)
• CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin
  di: Rubin Lubomirov, et al.
  Pubblicazione: (2025)
• CYP2C19 Genotype‐Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure
  di: Kayla R. Tunehag, et al.
  Pubblicazione: (2025)